STAA - STAAR Surgical Company

STAAR Surgical Announces Participation in Upcoming Investor Conferences

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas.

May 21, 2026 12:01 PM • businesswire.com

STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround

STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing to $5.2M net income. China's market rebound, normalized inventory, and rapid EVO+ ICL adoption drove topline strength, while disciplined OpEx and manufacturing efficiency boosted margins to 73.6%. STAA is benefiting from a structural shift toward lens-based refractive surgery, gaining U.S. share despite a shrinking laser market and expanding its addressable market via FDA approval.

May 16, 2026 06:10 AM • seekingalpha.com

Why It's Time To Take Profits In This Top-Rated Medical Stock

Staar Surgical shares catapulted Thursday after the eye surgery outlet obliterated first-quarter profit expectations.

May 14, 2026 08:06 AM • investors.com

STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript

STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript

May 13, 2026 09:20 PM • seekingalpha.com

STAAR Surgical Q1 Earnings Call Highlights

STAAR Surgical NASDAQ: STAA said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls following a difficult 2025.

May 13, 2026 08:14 PM • marketbeat.com

Compared to Estimates, Staar Surgical (STAA) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Staar Surgical (STAA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

May 13, 2026 02:30 PM • zacks.com

Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to a loss of $0.52 per share a year ago.

May 13, 2026 02:15 PM • zacks.com

STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the first quarter ended April 3, 2026, on Wednesday, May 13, 2026, after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and bus.

May 04, 2026 12:01 PM • businesswire.com

A Look at Staar Surgical Co (STAA) After 3.1% Gain -- GF Value $29.11 vs Price $27.19

On May 01, 2026, Staar Surgical Co (STAA) shares rose 3.1% today, bringing the current price to $27.19. Over the past 52 weeks, the stock has fluctuated between

May 01, 2026 02:18 PM • gurufocus.com

McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 30, 2026 07:06 AM • zacks.com

Staar Surgical (STAA) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 29, 2026 07:02 AM • zacks.com

STAAR Surgical Shares Jump 25% on Blowout $90M Sales Outlook

STAAR Surgical (STAA) stock surged more than 25% on Thursday after the ophthalmic implant maker projected first-quarter net sales would top $90 million, more th

Apr 09, 2026 08:32 AM • gurufocus.com

Stock Futures Drop After Ceasefire Instability, Inflation Data

The major indexes are pulling back after yesterday's ceasefire-related surge

Apr 09, 2026 05:07 AM • schaeffersresearch.com

STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid

STAAR Surgical Company has seen a dramatic valuation reset, now trading at a $1bn market cap after failed acquisition talks and underwhelming US growth. Q1 2026 net sales are expected to exceed $90m, driven by a strong rebound in China and signaling potential for record annual revenues. Despite operational challenges and competitive pressures, STAA's proprietary Collamer lens and expanded US indications provide incremental growth opportunities.

Apr 09, 2026 04:56 AM • seekingalpha.com

Wall Street Breakfast Podcast: STAAR Prelims Signal Upside

STAAR Surgical (STAA) expects Q1 net sales to exceed $90M, more than doubling year-over-year, driven primarily by China and double-digit growth in the Americas. Disney plans 1,000 job cuts in marketing overhaul under new CEO.

Apr 09, 2026 03:09 AM • seekingalpha.com

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced preliminary net sales for the first quarter ended April 3, 2026. STAAR is announcing its preliminary net sales in advance of its quarterly earnings announcement because it expects to be interacting with members of the investment community, as well as with surgeons and other members of t.

Apr 08, 2026 12:01 PM • businesswire.com

Surging Earnings Estimates Signal Upside for Staar Surgical (STAA) Stock

Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Apr 06, 2026 09:21 AM • zacks.com

Defender Capital LLC. Takes $15.43 Million Position in STAAR Surgical Company $STAA

Defender Capital LLC. purchased a new stake in shares of STAAR Surgical Company (NASDAQ: STAA) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 668,222 shares of the medical instruments supplier's stock, valued at approximately $15,429,000. STAAR Surgical accounts for

Mar 26, 2026 12:45 AM • defenseworld.net

Insider Buying: STAAR Surgical (NASDAQ:STAA) Director Purchases $5,881,076.37 in Stock

STAAR Surgical Company (NASDAQ: STAA - Get Free Report) Director Broadwood Partners, L.P. purchased 316,017 shares of the business's stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $18.61 per share, with a total value of $5,881,076.37. Following the completion of the purchase, the director owned

Mar 16, 2026 12:21 AM • defenseworld.net

Insider Buying: STAAR Surgical (NASDAQ:STAA) Director Purchases $5,425,707.84 in Stock

STAAR Surgical Company (NASDAQ: STAA - Get Free Report) Director Broadwood Partners, L.P. purchased 299,432 shares of the business's stock in a transaction on Thursday, March 12th. The shares were purchased at an average price of $18.12 per share, with a total value of $5,425,707.84. Following the completion of the purchase, the director owned 15,807,825 shares

Mar 16, 2026 12:21 AM • defenseworld.net

Staar Surgical price target raised to $27 from $22 at Mizuho

$27.00 (was $29.40)

Anthony Petrone · Mizuho Securities

May 14, 2026 07:21 AM • TheFly

Staar Surgical price target raised to $32 from $27 at Canaccord

$32.00 (was $29.40)

Canaccord Genuity

May 14, 2026 07:08 AM • TheFly

Staar Surgical upgraded to Outperform from Neutral at Wedbush

$40.00 (was $29.40)

Wedbush

May 14, 2026 07:02 AM • TheFly

Staar Surgical price target raised to $33 from $16 at Piper Sandler

$33.00 (was $29.40)

Adam Maeder · Piper Sandler

May 14, 2026 06:54 AM • TheFly

Staar Surgical price target raised to $31 from $18 at Stifel

$31.00 (was $29.40)

Thomas Stephan · Stifel Nicolaus

May 14, 2026 06:41 AM • TheFly

Staar Surgical upgraded to Buy from Hold at Canaccord

$27.00 (was $25.21)

Canaccord Genuity

Apr 09, 2026 04:53 AM • TheFly

STAAR Surgical (STAA) PT Lowered to $18 at Stifel After Noisy Q4 Results

$18.00 (was $19.22)

Stifel Nicolaus

Mar 04, 2026 07:39 AM • StreetInsider

Staar Surgical price target lowered to $19 from $28 at Stifel

$19.00 (was $17.58)

Stifel Nicolaus

Feb 09, 2026 06:57 AM • TheFly

Staar Surgical initiated with a Neutral at Wedbush

$26.00 (was $18.16)

Wedbush

Feb 03, 2026 08:00 AM • TheFly

Staar Surgical resumed with an Underweight at Morgan Stanley

$13.00 (was $20.97)

Morgan Stanley

Jan 16, 2026 06:24 AM • TheFly

STAAR Surgical (STAA) PT Lowered to $22 at Canaccord Genuity

$22.00 (was $21.02)

John Young · Canaccord Genuity

Jan 15, 2026 10:17 AM • StreetInsider

Staar Surgical price target raised to $30.75 from $28 at Wells Fargo

$30.75 (was $25.38)

Simran Kaur · Wells Fargo

Dec 10, 2025 06:53 AM • TheFly

STAAR Surgical (STAA) PT Raised to $30.75 at Canaccord Genuity

$30.75 (was $25.89)

John Young · Canaccord Genuity

Dec 09, 2025 09:51 AM • StreetInsider

Canaccord Genuity Reiterates Hold Rating on STAAR Surgical (STAA)

$28.00 (was $25.32)

John Young · Canaccord Genuity

Oct 21, 2025 06:40 AM • StreetInsider

Staar Surgical downgraded to Hold from Buy at Stifel

$28.00 (was $26.90)

Thomas Stephan · Stifel Nicolaus

Aug 06, 2025 09:01 PM • TheFly

BTIG Upgrades STAAR Surgical (STAA) to Buy

$46.00 (was $38.07)

Ryan Zimmerman · BTIG

Jun 11, 2024 01:31 AM • StreetInsider

STAAR Surgical (STAA) PT Raised to $60 at Jefferies, 'Strong Start to 2024'

$60.00 (was $50.59)

Raj Denhoy · Jefferies

Apr 09, 2024 04:57 AM • StreetInsider

STAAR Surgical (STAA) PT Raised to $46 at Canaccord Genuity

$46.00 (was $48.68)

John Young · Canaccord Genuity

Apr 08, 2024 03:06 AM • StreetInsider

Staar Surgical upgraded to Outperform after Q1 beat at William Blair

$45.03 (was $45.54)

Margaret Kaczor · William Blair

Apr 04, 2024 11:25 AM • TheFly

STAAR Surgical (STAA) Stock Receives A $85 Price Target

$85.00 (was $68.56)

Stephens Stephens · Stephens

Jan 11, 2023 09:54 AM • Pulse 2.0